Communications Medicine

A selective open access journal from @NaturePortfolio publishing research, reviews & commentary across clinical, translational & public health research fields

[Communications Medicine @CommsMedicine]

🚨 NEW research⚕️ 🩺

Cupelli et al. explore a decoy peptide approach to correcting autoimmune-acquired long QT 🫀 using a guinea pig model.

https://t.co/ej9tbxFM5z
#CardiacResearch

[Communications Medicine @CommsMedicine]

🚨 NEW research⚕️ 🩺

Knaan et al. examine metabolic and behavioral adaptations to a 12-week supervised aerobic exercise program in adults.

https://t.co/NqpI74VLQP
#Exercise #BehavioralHealth

[Communications Medicine @CommsMedicine]

🚨 NEW research⚕️ 🩺

Borjigin et al. test a personalized cochlear implant strategy that delivers low-rate timing cues to each user’s most sensitive cochlear location.

https://t.co/lJrLdoaFUM

#PersonalizedMedicine

[Communications Medicine @CommsMedicine]

🚨 NEW research⚕️ 🩺

Mousavi, Chen, Miliku et al. analyze dietary, family, and neighbourhood data from Canadian preschoolers to identify predictors of ultra-processed food intake.

https://t.co/96jgq9RSgU
#ChildHealth

[Nature Conferences @NatureConf]

From discovery to real-world impact: what’s next for #PrecisionHealth? Nature Health Chief Editor @drbenjohnson shares his take. Join us at Reframing Precision Medicine, 13–15 Oct, London. Abstracts close 30 June #RPM26 https://t.co/i103UVmdtP

[Communications Medicine @CommsMedicine]

🚨 NEW COLLECTION! 💡

Submit your research on Lung Cancer!

We invite papers that deepen our understanding of lung cancer and improve patient outcomes and quality of life.

https://t.co/V4SyKdmI7h
#CancerResearch

[Communications Medicine @CommsMedicine]

🚨 NEW COLLECTION! 💡

Submit your research on Inflammation, Immunometabolism, and Chronic Disease!

https://t.co/yBwFsiDYCp
#ChronicDisease #Inflammation

[Communications Medicine @CommsMedicine]

📢 Communication Medicine is at the 37th Pezcoller Symposium ‘CANCER EVOLUTIONARY TRAJECTORIES’ today & tomorrow🎉

📩 Our editor Katharine Barnes would love to connect with researchers! Get in touch to schedule a meeting.

#Pezcoller26 #CancerResearch

[Communications Medicine @CommsMedicine]

🚨 NEW COMMENT ⚕️💡

Calvert et al. highlight how patient-reported outcomes provide critical evidence for drug regulation, reimbursement, and clinical care.

https://t.co/mcL9U6WslK
#PatientOutcomes

[Eric YF Wan @EricWan_HKU]

Our @CommsMedicine paper found that patients of minor #ailment service #MAS by #community #pharmacists report high levels of #symptom #resolution, #satisfaction, and #enablement, suggesting MAS may alleviate pressure on higher-cost healthcare services.
https://t.co/YtFKGyEGcc

[Communications Medicine @CommsMedicine]

📢 Communication Medicine will be at the 37th Pezcoller Symposium ‘CANCER EVOLUTIONARY TRAJECTORIES’ next week June 22-23rd 🎉

📩 Our editor Katharine Barnes will be attending & would love to connect with researchers!

#Pezcoller26 #CancerResearch

[Communications Medicine @CommsMedicine]

🚨 NEW COMMENT ⚕️💡

Calvert et al. summarise evidence on the value of patient-reported outcomes throughout the drug development pipeline and provide a summary of guidance documents to support optimal assessment in drug development.

https://t.co/LbVS09tDdN

[Communications Medicine @CommsMedicine]

🚨 NEW COMMENT ⚕️💡

Desachy et al. reflect on the Precision Medicine Initiative after a decade and share their perspective as pharmaceutical statisticians while proposing strategic shifts to realize its full potential.

https://t.co/YNQ9s7y5Pa

[Nature Portfolio @NaturePortfolio]

A study in Communications Medicine explores whether a special, fat-based diet could be a safe and effective treatment for adults with anorexia nervosa. Participants showed significant improvements in eating disorder symptoms. https://t.co/MM9c5vx3CA

[Communications Medicine @CommsMedicine]

🚨 NEW COMMENT ⚕️💡

Xiong et al. discuss the Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Initiative, funded with $88 million over five years, which aims to advance health research across Africa.

https://t.co/bUdcd0YBPd

[Himel Mallick, PhD, FASA (He/him) @Mallick_Himel]

Did we pull off the largest microbiome meta-analysis to date in cancer immunotherapy?

🔥 Yes, we did. 🔥

🎉 Massive congrats to Xinyang Zhang for spearheading the effort, and thanks to the @RahnavardLab for the collaboration! 🙌

📄 Read it in @CommsMedicine: https://t.co/IcOEZWILM3

#Statistics #Biostatistics #Omics #DataScience #Microbiome #Melanoma #Immunotherapy

[Baszucki Group @BaszuckiGroup]

A pilot study published today in @CommsMedicine demonstrates the potential for a new approach to treating anorexia nervosa. The research from @UCSDMedSchool, led by @GuidoFrank, reports that a ketogenic nutritional intervention was feasible and safe for patients with weight-normalized anorexia nervosa. Significant improvements were observed in eating disorder symptoms, with nearly 3 in 4 of study completers no longer meeting criteria for an anorexia nervosa diagnosis, and all completers experiencing an improvement in depression scores.

“This study highlights the promise of dietary interventions that target underlying neurometabolic dysfunction for even the most intractable psychiatric conditions like anorexia nervosa,” said @janellison, co-founder and president of Baszucki Group, which funded the study. “We hope this work drives awareness and support for researching and delivering ketogenic therapy for eating disorders, providing new hope for patients and their families.”

Read the paper: https://t.co/3YHOblwpAd

Read the press release: https://t.co/3tWMr4uwzk

Learn more about the extension for the study for patients with both anorexia nervosa and bulimia nervosa: https://t.co/h1jXhErX7U

[Communications Medicine @CommsMedicine]

🚨 NEW COLLECTION! 💡

Submit your research on “The expanding therapeutic landscape of GLP 1 receptor agonists”

This Collection calls for papers that investigate the expanding clinical and biological roles of GLP‑1 RAs.

https://t.co/J0HvXU4O16
#GLP1 #Therapeutics

[Communications Medicine @CommsMedicine]

🚨 NEW REVIEW⚕️ 🩺

Tao et al. summarize evidence linking HIV-1 Env sequence characteristics to reduced bnAb susceptibility, including in vivo selection data in animal models and human studies, and in vitro selection and susceptibility data.

https://t.co/uwG0nWpDg8

[Communications Medicine @CommsMedicine]

🚨 NEW REVIEW⚕️ 🩺

Sridharan et al . examine the potential contributing role of microplastics and nanoplastics in prostate, bladder, and renal cell carcinoma as well as their potential in therapeutics as advanced drug delivery platforms.

https://t.co/RuHux60ERe